Literature DB >> 20555113

Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

P G Casali1, J-Y Blay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20555113     DOI： 10.1093/annonc/mdq208

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  84 in total

Review 1.  Malignant Rectal Gastrointestinal Stromal Tumour: Case Report and Review of Literature.

Authors:  Ana Catarina Lagos; Inês Marques; Jorge Reis; Irene Martins; Beatriz Neves
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  A Gastrointestinal Stromal Tumor Presenting as an Emergency: a Case Report.

Authors:  Konstantinos Bouliaris; Aikaterini Michopoulou; Konstantinos Spanos; Vassilios Simopoulos; Ioannis Bolanis; Stylianos Germanos
Journal:  J Gastrointest Cancer       Date:  2012-09

3.  Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs.

Authors:  J F Emile; S Brahimi; J M Coindre; P P Bringuier; G Monges; P Samb; L Doucet; I Hostein; B Landi; M P Buisine; A Neuville; O Bouché; P Cervera; J L Pretet; J Tisserand; A Gauthier; A Le Cesne; J C Sabourin; J Y Scoazec; S Bonvalot; C L Corless; M C Heinrich; J Y Blay; P Aegerter
Journal:  Med Oncol       Date:  2011-09-28       Impact factor: 3.064

4.  [Are sarcoma centers needed in Germany? Experience gained with the Bonner GIST register].

Authors:  E Wardelmann; S Merkelbach-Bruse; H U Schildhaus; R Büttner
Journal:  Pathologe       Date:  2011-02       Impact factor: 1.011

Review 5.  Correlations between imatinib pharmacokinetics, pharmacodynamics, adherence, and clinical response in advanced metastatic gastrointestinal stromal tumor (GIST): an emerging role for drug blood level testing?

Authors:  Margaret von Mehren; Nicolas Widmer
Journal:  Cancer Treat Rev       Date:  2010-11-24       Impact factor: 12.111

Review 6.  Intolerance to imatinib in gastrointestinal stromal tumors: a case report and a review of literature.

Authors:  Yousra Akasbi; Samia Arifi; Sami Aziz Brahmi; Fatima Zahra El Mrabet; Nawfel Mellas; Fatima Zahra Mernisi; Omar El Mesbahi
Journal:  J Gastrointest Cancer       Date:  2014-12

7.  Duration of adjuvant treatment following radical resection of metastases from gastrointestinal stromal tumours.

Authors:  Margherita Nannini; Maria Abbondanza Pantaleo; Alessandra Maleddu; Maristella Saponara; Anna Mandrioli; Cristian Lolli; Maria Caterina Pallotti; Lidia Gatto; Donatella Santini; Paola Paterini; Valerio DI Scioscio; Fausto Catena; Pietro Fusaroli; Antonio Daniele Pinna; Angelo Paolo Dei Tos; Guido Biasco
Journal:  Oncol Lett       Date:  2011-12-23       Impact factor: 2.967

8.  Successful Treatment Toward Gastrointestinal Stromal Tumors with Aggressive Behavior.

Authors:  Landolsi Sana; Mannai Saber
Journal:  J Gastrointest Cancer       Date:  2015-09

Review 9.  [Translational research and diagnosis in GIST].

Authors:  E Wardelmann
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

10.  Value of epithelioid morphology and PDGFRA immunostaining pattern for prediction of PDGFRA mutated genotype in gastrointestinal stromal tumors (GISTs).

Authors:  Abbas Agaimy; Claudia Otto; Alexander Braun; Helene Geddert; Inga-Marie Schaefer; Florian Haller
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.